Pharma Journalist -

Roche announced results from the global phase III ALUR study showing that Alecensa® significantly reduced the risk of disease worsening or death (progression-free survival, PFS) by 85%…
Read More...

Bristol-Myers Squibb Company announced that it has completed the previously announced planned acquisition of IFM Therapeutics. The transaction includes full rights to IFM’s…
Read More...

Project ALS and Amylyx Pharmaceuticals announced a collaboration to undertake pre-clinical studies with Amylyx’s oral compound AMX0035 to advance the understanding of the compound’s…
Read More...

Alcami Corporation announces the formation of a Center of Excellence at its world-class active pharmaceutical ingredient (API) development and manufacturing facility in Germantown,…
Read More...

Immune Therapeutics, Inc., a specialty pharmaceutical company focused on developing and commercializing Lodonal™, its patented, affordable, non-toxic therapy for the management of…
Read More...

Sanofi announced that the U.S. Food and Drug Administration (FDA) granted tentative approval for Admelog® (insulin lispro injection) 100 Units/mL, a rapid-acting human insulin analog.…
Read More...

Cambrex Corporation announced that it is expanding its High Point, NC facility with the addition of a new $3.2 million, 11,000 sq. ft. analytical laboratory. The investment comes in…
Read More...

Labcyte Inc. and SEngine Precision Medicine announced the companies are collaborating to fulfill the promise of personalized medicine by employing Labcyte’s advanced acoustic liquid…
Read More...

The U.S. Food and Drug Administration issued a historic action making the first gene therapy available in the United States, ushering in a new approach to the treatment of cancer and…
Read More...

Alimera Sciences, Inc., a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharmaceuticals, announced that Alimera Sciences…
Read More...